News
According to the terms of the agreement, Sanofi will acquire London-based Vicebio’s entire share capital for an upfront ...
French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio for a total ...
5d
Pharmaceutical Technology on MSNSanofi to acquire Vicebio’s share capital for $1.15bn upfrontSanofi has signed an agreement to acquire Vicebio’s share capital for $1.15bn upfront, to expand its vaccine development capabilities.
Sanofi tightens grip on RSV, paying $1.15B upfront for Vicebio and boosting its pipeline beyond mRNA
Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...
French pharmaceuticals giant Sanofi has agreed to acquire privately-owned British biotech firm, Vicebio, in a deal worth up ...
Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was ...
Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...
Sanofi has announced that it will be expanding its respiratory vaccines pipeline by acquiring UK-based Vicebio for up to ...
4d
Investing News Network on MSNBiotech and Pharma Market Update: Q2 2025 in ReviewThe second quarter of 2025 was a period of dynamic evolution within the biotech and pharma sectors. Critical factors like ...
4d
TipRanks on MSNBB Biotech Outperforms Nasdaq Biotech Index in Q2 2025An update from BB Biotech ( ($CH:BION) ) is now available. In Q2 2025, BB Biotech outperformed the Nasdaq Biotech Index, with a 10.2% increase in ...
3h
The Argus on MSNWeight loss drug warning with more than one in two adults in city obese or overweightPeople are buying weight loss drugs online but the cut-price deals may not be what they seem to be, health chiefs warned.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results